Beyond sidestepping people’s fear of needles, these vaccines would also make it easier to store and distribute ahead of ...

BioNTech and Moderna COVID-19 vaccines use mRNA technology in their vaccines to protect us from the spread of the disease.

Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Moderna (MRNA) to $38 from $70 and keeps an Equal Weight rating on the ...

The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research ...

In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

There is a distrust of, and dislike of mRNA vaccines among some people. Though the risk of death from Covid still exceeds ...

Five years on, COVID-19 has claimed over 20 million lives globally. Despite vaccines, the virus continues to evolve, leaving ...

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.